世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5441 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、多発性硬化症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、脳室内）、用途別市場規模（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症（SPMS）、進行型再発性多発性硬化症（PRMS））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・多発性硬化症幹細胞治療の市場動向 ・企業の競争状況、市場シェア ・多発性硬化症幹細胞治療の種類別市場規模（静脈内、脳室内） ・多発性硬化症幹細胞治療の用途別市場規模（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症（SPMS）、進行型再発性多発性硬化症（PRMS）） ・多発性硬化症幹細胞治療の北米市場規模2016-2027（アメリカ、カナダ） ・多発性硬化症幹細胞治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・多発性硬化症幹細胞治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多発性硬化症幹細胞治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・多発性硬化症幹細胞治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（American CryoStem、Athersys、Celgene Cellular Therapeutics、Cell Cure Neurosciences） ・結論

Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling.
The introduction of mesenchymal stem cells therapy is one of the most promising investigational approach to treat multiple sclerosis, the global multiple sclerosis market will witness growth in the forthcoming years. it has been observed that the American cryostem and celgene cellular therapeutics have their stem cell therapy candidates for the treatment of multiple sclerosis in phase I stage of development.

Market Analysis and Insights: Global Stem Cell Therapy for Multiple Sclerosis Market
The global Stem Cell Therapy for Multiple Sclerosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Therapy for Multiple Sclerosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Therapy for Multiple Sclerosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Therapy for Multiple Sclerosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Therapy for Multiple Sclerosis market.

Global Stem Cell Therapy for Multiple Sclerosis Scope and Market Size
Stem Cell Therapy for Multiple Sclerosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Multiple Sclerosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravenous
Intracerebroventricular

Segment by Application
Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary Progressive Multiple Sclerosis (PPMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Progressive Relapsing Multiple Sclerosis (PRMS)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
American CryoStem
Athersys
Celgene Cellular Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Intracerebroventricular
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Relapsing-Remitting Multiple Sclerosis (RRMS)
1.3.3 Primary Progressive Multiple Sclerosis (PPMS)
1.3.4 Secondary Progressive Multiple Sclerosis (SPMS)
1.3.5 Progressive Relapsing Multiple Sclerosis (PRMS)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Perspective (2016-2027)
2.2 Stem Cell Therapy for Multiple Sclerosis Growth Trends by Regions
2.2.1 Stem Cell Therapy for Multiple Sclerosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stem Cell Therapy for Multiple Sclerosis Historic Market Share by Regions (2016-2021)
2.2.3 Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Regions (2022-2027)
2.3 Stem Cell Therapy for Multiple Sclerosis Industry Dynamic
2.3.1 Stem Cell Therapy for Multiple Sclerosis Market Trends
2.3.2 Stem Cell Therapy for Multiple Sclerosis Market Drivers
2.3.3 Stem Cell Therapy for Multiple Sclerosis Market Challenges
2.3.4 Stem Cell Therapy for Multiple Sclerosis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue (2016-2021)
3.1.2 Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Players (2016-2021)
3.2 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Multiple Sclerosis Revenue
3.4 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Multiple Sclerosis Revenue in 2020
3.5 Stem Cell Therapy for Multiple Sclerosis Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Stem Cell Therapy for Multiple Sclerosis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Type (2016-2021)
4.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2022-2027)

5 Stem Cell Therapy for Multiple Sclerosis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Application (2016-2021)
5.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size (2016-2027)
6.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type
6.2.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021)
6.2.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027)
6.2.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2027)
6.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application
6.3.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021)
6.3.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027)
6.3.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2027)
6.4 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country
6.4.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021)
6.4.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size (2016-2027)
7.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type
7.2.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021)
7.2.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027)
7.2.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2027)
7.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application
7.3.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021)
7.3.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027)
7.3.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2027)
7.4 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country
7.4.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021)
7.4.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size (2016-2027)
8.2 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Type
8.2.1 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Application
8.3.1 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region
8.4.1 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size (2016-2027)
9.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Type
9.2.1 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021)
9.2.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027)
9.2.3 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2027)
9.3 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Application
9.3.1 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021)
9.3.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027)
9.3.3 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2027)
9.4 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country
9.4.1 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021)
9.4.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size (2016-2027)
10.2 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Type
10.2.1 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Application
10.3.1 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country
10.4.1 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 American CryoStem
11.1.1 American CryoStem Company Details
11.1.2 American CryoStem Business Overview
11.1.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Introduction
11.1.4 American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
11.1.5 American CryoStem Recent Development
11.2 Athersys
11.2.1 Athersys Company Details
11.2.2 Athersys Business Overview
11.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Introduction
11.2.4 Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
11.2.5 Athersys Recent Development
11.3 Celgene Cellular Therapeutics
11.3.1 Celgene Cellular Therapeutics Company Details
11.3.2 Celgene Cellular Therapeutics Business Overview
11.3.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Introduction
11.3.4 Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
11.3.5 Celgene Cellular Therapeutics Recent Development
11.4 Cell Cure Neurosciences
11.4.1 Cell Cure Neurosciences Company Details
11.4.2 Cell Cure Neurosciences Business Overview
11.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Introduction
11.4.4 Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
11.4.5 Cell Cure Neurosciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of Intracerebroventricular
Table 4. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2016-2021)
Table 8. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2022-2027)
Table 10. Stem Cell Therapy for Multiple Sclerosis Market Trends
Table 11. Stem Cell Therapy for Multiple Sclerosis Market Drivers
Table 12. Stem Cell Therapy for Multiple Sclerosis Market Challenges
Table 13. Stem Cell Therapy for Multiple Sclerosis Market Restraints
Table 14. Global Stem Cell Therapy for Multiple Sclerosis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players (2016-2021)
Table 16. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2020)
Table 17. Ranking of Global Top Stem Cell Therapy for Multiple Sclerosis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
Table 21. Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2016-2021)
Table 25. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2016-2021)
Table 29. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2022-2027) & (US$ Million)
Table 61. American CryoStem Company Details
Table 62. American CryoStem Business Overview
Table 63. American CryoStem Stem Cell Therapy for Multiple Sclerosis Product
Table 64. American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021) & (US$ Million)
Table 65. American CryoStem Recent Development
Table 66. Athersys Company Details
Table 67. Athersys Business Overview
Table 68. Athersys Stem Cell Therapy for Multiple Sclerosis Product
Table 69. Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021) & (US$ Million)
Table 70. Athersys Recent Development
Table 71. Celgene Cellular Therapeutics Company Details
Table 72. Celgene Cellular Therapeutics Business Overview
Table 73. Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Product
Table 74. Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021) & (US$ Million)
Table 75. Celgene Cellular Therapeutics Recent Development
Table 76. Cell Cure Neurosciences Company Details
Table 77. Cell Cure Neurosciences Business Overview
Table 78. Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Product
Table 79. Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021) & (US$ Million)
Table 80. Cell Cure Neurosciences Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. Intracerebroventricular Features
Figure 4. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2020 VS 2027
Figure 5. Relapsing-Remitting Multiple Sclerosis (RRMS) Case Studies
Figure 6. Primary Progressive Multiple Sclerosis (PPMS) Case Studies
Figure 7. Secondary Progressive Multiple Sclerosis (SPMS) Case Studies
Figure 8. Progressive Relapsing Multiple Sclerosis (PRMS) Case Studies
Figure 9. Stem Cell Therapy for Multiple Sclerosis Report Years Considered
Figure 10. Global Stem Cell Therapy for Multiple Sclerosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Stem Cell Therapy for Multiple Sclerosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions: 2020 VS 2027
Figure 13. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2022-2027)
Figure 14. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players in 2020
Figure 15. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue in 2020
Figure 17. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2016-2021)
Figure 18. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2022-2027)
Figure 19. North America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2016-2027)
Figure 21. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2016-2027)
Figure 22. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2016-2027)
Figure 23. United States Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2016-2027)
Figure 27. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2016-2027)
Figure 28. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2016-2027)
Figure 29. Germany Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2016-2027)
Figure 39. China Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2016-2027)
Figure 47. Latin America Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2016-2027)
Figure 48. Latin America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2016-2027)
Figure 49. Mexico Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2016-2027)
Figure 55. Turkey Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. American CryoStem Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
Figure 59. Athersys Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
Figure 60. Celgene Cellular Therapeutics Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
Figure 61. Cell Cure Neurosciences Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---